May 31, 2024
2 min watch
Save
VIDEO: Vevye offers ‘excellent’ safety, efficacy for dry eye treatment
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Preeya K. Gupta, MD, discusses Vevye’s positive impact on the signs and symptoms of dry eye disease.
According to Gupta, the low side effect profile and proprietary vehicle make it easier for patients to tolerate Vevye (cyclosporine ophthalmic solution 0.1%, Harrow).
“It has an excellent safety and tolerability profile, but also efficacy profile, with several studies behind it,” she said. “It’s something that, since it’s a newer molecule, patients actually do have good access to the drug in terms of coverage.”
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Gupta reports consulting for Harrow.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.